SRD5A3 and hepatocellular carcinoma: (56) demonstrated that SRD5A3 is upregulated in hepatocellular carcinoma (HCC) tissues, and higher SRD5A3 level predicts poor OS, progression-free survival, relapse-free survival, and disease-specific survival in HCC patients.